BALTEZOR; Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for BALTEZOR; Michael.The latest application filed is for "sorafenib particles and uses thereof".
Company Profile
20.11.31
- BALTEZOR; Michael - Lawrence KS
- Baltezor; Michael - Shawnee KS
Patent Activity
| Patent | Date |
|---|---|
| Sorafenib particles and uses thereof App 20220241257 - SITTENAUER; Jacob ; et al. | 2022-08-04 |
| Treatment of Bladder Cancer by Local Administration of Taxane Particles App 20220096423 - DIZEREGA; Gere S. ; et al. | 2022-03-31 |
| Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer App 20220047513 - DIZEREGA; Gere S. ; et al. | 2022-02-17 |
| Lapatinib particles and uses thereof App 20220023215 - SITTENAUER; Jacob ; et al. | 2022-01-27 |
| Taxane Particles and Their Use App 20210393569 - BALTEZOR; Michael ; et al. | 2021-12-23 |
| Ciprofloxacin Polymorph And Its Use App 20210387961 - WILLIAMS; Mark ; et al. | 2021-12-16 |
| Methods for treating lung disorders Grant 11,160,754 - Baltezor , et al. November 2, 2 | 2021-11-02 |
| Taxane particles and their use Grant 11,123,322 - Baltezor , et al. September 21, 2 | 2021-09-21 |
| Ciprofloxacin polymorph and its use Grant 11,104,663 - Williams , et al. August 31, 2 | 2021-08-31 |
| Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles App 20210259959 - diZerega; Gere S. ; et al. | 2021-08-26 |
| Methods For Isolating Tumor-specific Immune Cells From A Subject For Adoptive Cell Therapy And Cancer Vaccines App 20210214683 - DIZEREGA; Gere S. ; et al. | 2021-07-15 |
| Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer Grant 11,058,639 - Dizerega , et al. July 13, 2 | 2021-07-13 |
| Formulations And Methods For The Prevention And Treatment Of Tumor Metastasis And Tumorigenesis App 20210186972 - Rudloff; Udo ; et al. | 2021-06-24 |
| Taxane particles and their use Grant 10,993,927 - Baltezor , et al. May 4, 2 | 2021-05-04 |
| Taxane Particles and Their Use App 20210000786 - BALTEZOR; Michael ; et al. | 2021-01-07 |
| Taxane Particles and Their Use App 20200405684 - BALTEZOR; Michael ; et al. | 2020-12-31 |
| Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment o App 20200261367 - DIZEREGA; Gere S. ; et al. | 2020-08-20 |
| Glucocorticoid Particles and Their Use App 20200246355 - Kind Code | 2020-08-06 |
| Ciprofloxacin Polymorph And Its Use App 20200247780 - Kind Code | 2020-08-06 |
| Taxane particles and their use Grant 10,729,673 - Baltezor , et al. | 2020-08-04 |
| Taxane Particles and Their Use App 20200163928 - BALTEZOR; Michael ; et al. | 2020-05-28 |
| Taxane Particles and Their Use App 20200101039 - BALTEZOR; Michael ; et al. | 2020-04-02 |
| Methods for Treating Lung Disorders App 20200060969 - Baltezor; Michael ; et al. | 2020-02-27 |
| Methods for treating lung disorders Grant 10,507,181 - Baltezor , et al. Dec | 2019-12-17 |
| Taxane particles and their use Grant 10,507,195 - Baltezor , et al. Dec | 2019-12-17 |
| Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer App 20190365698 - BALTEZOR; Michael ; et al. | 2019-12-05 |
| Treatment of Kidney Tumors by Intratumoral Injection of Taxane Particles App 20190365699 - BALTEZOR; Michael ; et al. | 2019-12-05 |
| Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer Vaccines App 20190365700 - Dizerega; Gere S. ; et al. | 2019-12-05 |
| Methods for Treating Lung Disorders App 20190314277 - Baltezor; Michael ; et al. | 2019-10-17 |
| Methods for treating lung disorders Grant 10,398,646 - Baltezor , et al. Sep | 2019-09-03 |
| Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles App 20190254957 - diZerega; Gere S. ; et al. | 2019-08-22 |
| Treatment of Bladder Cancer by Local Administration of Taxane Particles App 20190209514 - DIZEREGA; Gere S. ; et al. | 2019-07-11 |
| Treatment of Bladder Cancer by Intratumoral Injection of Taxane Particles App 20190209515 - DIZEREGA; Gere S. ; et al. | 2019-07-11 |
| Methods for Treating Lung Disorders App 20180360748 - Baltezor; Michael ; et al. | 2018-12-20 |
| System and Methods for Tissue Sterilization App 20180353630 - Farthing; Joseph ; et al. | 2018-12-13 |
| Taxane Particles and Their Use App 20180169058 - BALTEZOR; Michael ; et al. | 2018-06-21 |
| Methods for making compound particles Grant 9,918,957 - Baltezor , et al. March 20, 2 | 2018-03-20 |
| Taxane particles and their use Grant 9,814,685 - Baltezor , et al. November 14, 2 | 2017-11-14 |
| Methods for Making Compound Particles App 20170224650 - BALTEZOR; Michael ; et al. | 2017-08-10 |
| Methods for Making Compound Particles App 20160374953 - BALTEZOR; Michael ; et al. | 2016-12-29 |
| Taxane Particles and Their Use App 20160354336 - BALTEZOR; Michael ; et al. | 2016-12-08 |
| Use of Paclitaxel Particles App 20150342872 - WILLIAMSON; Stephen K. ; et al. | 2015-12-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 